Intravenous N-acetylcysteine does not prevent post-ERCP pancreatitis (Q46577671)

23 December 2017

title

Intravenous N-acetylcysteine does not prevent post-ERCP pancreatitis (English)

1 reference

23 December 2017

1 reference

1 reference

23 December 2017

Jannis Kountouras

Jannis Kountouras

1 reference

23 December 2017

Panagiotis Katsinelos

Panagiotis Katsinelos

1 reference

23 December 2017

George Paroutoglou

George Paroutoglou

1 reference

23 December 2017

Kostas Mimidis

Kostas Mimidis

1 reference

23 December 2017

Athanasios Beltsis

Athanasios Beltsis

1 reference

23 December 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

23 December 2017

Gastrointestinal Endoscopy

published in

1 reference

23 December 2017

volume

1 reference

23 December 2017

issue

1 reference

23 December 2017

page(s)

105-111

1 reference

23 December 2017

Prevention of post-ERCP pancreatitis: a comprehensive review

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901574-9

Complications of endoscopic biliary sphincterotomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901574-9

Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901574-9

Complications of diagnostic and therapeutic ERCP: a prospective multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901574-9

Complications of endoscopic sphincterotomy. A prospective series with emphasis on the increased risk associated with sphincter of Oddi dysfunction and nondilated bile ducts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901574-9

What are the risks of diagnostic and therapeutic endoscopic retrograde cholangiopancreatography?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901574-9

Xanthine oxidase inhibitor in acute experimental pancreatitis in rats and mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901574-9

N‐acetylcysteine induces beneficial changes in the acinar cell cycle progression in the course of acute pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901574-9

The Role of Oxygen-derived Free Radicals in the Pathogenesis of Acute Pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901574-9

Pretreatment with allopurinol diminishes pancreatography-induced pancreatitis in a canine model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901574-9

High-dose allopurinol for prevention of post-ERCP pancreatitis: a prospective randomized double-blind controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901574-9

Beneficial effects of N-acetylcysteine on sodium taurocholate-induced pancreatitis in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901574-9

Major pathological mechanisms of acute pancreatitis are prevented by N-acetylcysteine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901574-9

Suppression of NF-kappaB activation and cytokine production by N-acetylcysteine in pancreatic acinar cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901574-9

Intravenous n-acetylcysteine, ascorbic acid and selenium-based anti-oxidant therapy in severe acute pancreatitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901574-9

Acetylcysteine to treat complications of pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901574-9

Endoscopic sphincterotomy complications and their management: an attempt at consensus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901574-9

A prospective, randomized, placebo-controlled trial of prednisone and allopurinol in the prevention of ERCP-induced pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901574-9

Pretreatment with methylprednisolone to prevent ERCP-induced pancreatitis: a randomized, multicenter, placebo-controlled clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901574-9

Serum amylase measured four hours after endoscopic sphincterotomy is a reliable predictor of postprocedure pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901574-9

Reactive oxygen species activate mitogen-activated protein kinases in pancreatic acinar cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901574-9

Leukocyte-endothelial cell interactions: molecular mechanisms and implications in gastrointestinal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901574-9

NF-kappaB/Rel activation in cerulein pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901574-9

NF-kappaB activation in acute pancreatitis: protective, detrimental, or inconsequential?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901574-9

Apoptosis in hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901574-9

Apoptosis, Inflammatory Bowel Disease and Carcinogenesis: Overview of International and Greek Experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901574-9

New molecular concepts of Barrett's esophagus: clinical implications and biomarkers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901574-9

Significance of glutathione in lung disease and implications for therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2805%2901574-9

10.1016/S0016-5107(05)01574-9

7 January 2021

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017